Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)
South Korea
· Delayed Price · Currency is KRW 6,060.00
+60.00 (1.00%)
At close: Mar 24, 2025, 3:30 PM KST
Jin Yang Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 29,694 | 12,340 | 12,308 | 9,538 | 5,229 | Upgrade
|
| Depreciation & Amortization | 2,024 | 2,655 | 2,291 | 2,154 | 2,048 | Upgrade
|
| Loss (Gain) From Sale of Assets | 77.14 | -0.86 | -24.9 | -9.53 | -0.6 | Upgrade
|
| Asset Writedown & Restructuring Costs | -24,919 | -2,263 | -3,556 | -1,451 | -1,217 | Upgrade
|
| Loss (Gain) From Sale of Investments | 621.53 | 9.65 | 97.96 | 13.48 | -762.1 | Upgrade
|
| Provision & Write-off of Bad Debts | -1,449 | 1,470 | 50.09 | -1,383 | -2,635 | Upgrade
|
| Other Operating Activities | 5,682 | 1,038 | 2,567 | 3,235 | 1,628 | Upgrade
|
| Change in Accounts Receivable | -2,755 | -2,754 | -918.28 | 132.24 | 2,788 | Upgrade
|
| Change in Inventory | 2,457 | -2,056 | -6,332 | -1,180 | -1,179 | Upgrade
|
| Change in Accounts Payable | 1,862 | -756.94 | 2,227 | -1,827 | -620.7 | Upgrade
|
| Change in Unearned Revenue | -30.13 | - | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | -473.3 | -1,148 | -1,263 | -7,251 | 966.43 | Upgrade
|
| Operating Cash Flow | 12,792 | 8,534 | 7,448 | 1,971 | 6,245 | Upgrade
|
| Operating Cash Flow Growth | 49.91% | 14.58% | 277.96% | -68.44% | -13.38% | Upgrade
|
| Capital Expenditures | -90,060 | -682.28 | -3,218 | -2,516 | -1,363 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.91 | 0.91 | 25.09 | 9.55 | 6.36 | Upgrade
|
| Sale (Purchase) of Intangibles | -397.44 | -851.25 | -1,423 | -207.08 | -8.33 | Upgrade
|
| Investment in Securities | 4,247 | 4,775 | -7,950 | -1,528 | 3,042 | Upgrade
|
| Other Investing Activities | -66.35 | -7 | -266.8 | -36.19 | -305 | Upgrade
|
| Investing Cash Flow | -86,276 | 3,236 | -12,833 | -4,278 | 1,372 | Upgrade
|
| Long-Term Debt Issued | 76,500 | - | - | 16,000 | - | Upgrade
|
| Total Debt Issued | 76,500 | - | - | 16,000 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -6,000 | -3,000 | Upgrade
|
| Long-Term Debt Repaid | -4,756 | -5,678 | -189.12 | -129.92 | -135.03 | Upgrade
|
| Total Debt Repaid | -4,756 | -5,678 | -189.12 | -6,130 | -3,135 | Upgrade
|
| Net Debt Issued (Repaid) | 71,744 | -5,678 | -189.12 | 9,870 | -3,135 | Upgrade
|
| Repurchase of Common Stock | - | - | -2,574 | - | - | Upgrade
|
| Dividends Paid | -1,619 | -1,616 | -1,118 | -1,118 | -1,118 | Upgrade
|
| Other Financing Activities | 20 | -110 | -1,700 | 100 | 100 | Upgrade
|
| Financing Cash Flow | 70,145 | -7,404 | -5,581 | 8,852 | -4,153 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -0.68 | - | - | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | - | - | - | -0 | Upgrade
|
| Net Cash Flow | -3,338 | 4,365 | -10,966 | 6,544 | 3,464 | Upgrade
|
| Free Cash Flow | -77,268 | 7,851 | 4,230 | -545.86 | 4,881 | Upgrade
|
| Free Cash Flow Growth | - | 85.62% | - | - | -24.58% | Upgrade
|
| Free Cash Flow Margin | -68.18% | 8.38% | 5.55% | -0.87% | 9.86% | Upgrade
|
| Free Cash Flow Per Share | -6200.88 | 691.58 | 338.84 | -48.25 | 436.92 | Upgrade
|
| Cash Interest Paid | 1,132 | 19.46 | 14.53 | 87.13 | 159.8 | Upgrade
|
| Cash Income Tax Paid | 2,339 | 172.1 | 1,130 | 430.46 | 466.02 | Upgrade
|
| Levered Free Cash Flow | -85,370 | 7,659 | -1,894 | -4,291 | 4,070 | Upgrade
|
| Unlevered Free Cash Flow | -84,210 | 8,518 | -1,091 | -4,161 | 4,172 | Upgrade
|
| Change in Net Working Capital | 3,095 | -1,970 | 5,702 | 7,943 | -833.24 | Upgrade
|
Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.